Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to talk about prostate cancer awareness and the FDA’s approval of a new pain medication. He also explains a ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Here we’ll dive into five of the best supplements for many people when taken daily. Before we dive into our list, it should be noted that nutrient supplementation is highly individualized based on age ...

Best TENS machines for effective chronic pain relief - Discover the benefits and drawbacks of using electrical nerve ...

Anti-anxiety medications have side effects and risks. But using them as a stopgap while you learn how to cope with symptoms can be helpful. Chest pain shouldn’t be ignored. If you’re ...